In-Class Cross-Reactivity among Hospitalized Patients with Hypersensitivity Reactions to Fluoroquinolones.
allergy
cross-reactivity
fluoroquinolone
hypersensitivity
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
15 06 2023
15 06 2023
Historique:
medline:
19
6
2023
pubmed:
8
5
2023
entrez:
8
5
2023
Statut:
ppublish
Résumé
Results from this large, multicenter study suggest that patients with a confirmed ciprofloxacin, moxifloxacin, or levofloxacin hypersensitivity reaction are likely to tolerate other fluoroquinolones. Avoiding different fluoroquinolones in patients labeled with a ciprofloxacin, moxifloxacin, or levofloxacin allergy may not always be mandatory. This was a study of patients with a ciprofloxacin, moxifloxacin, or levofloxacin hypersensitivity reaction and a documented electronic medical record administration of a different fluoroquinolone. Numerically, the most common reaction risk occurred with a challenge to moxifloxacin (2/19; 9.5%), followed by ciprofloxacin (6/89; 6.3%), and levofloxacin (1/44; 2.2%).
Identifiants
pubmed: 37154772
doi: 10.1128/aac.00374-23
pmc: PMC10269124
doi:
Substances chimiques
Fluoroquinolones
0
Moxifloxacin
U188XYD42P
Levofloxacin
6GNT3Y5LMF
Anti-Bacterial Agents
0
Ciprofloxacin
5E8K9I0O4U
Quinolines
0
Aza Compounds
0
Ofloxacin
A4P49JAZ9H
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0037423Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Allergy Asthma Immunol Res. 2017 Jul;9(4):347-359
pubmed: 28497922
J Investig Allergol Clin Immunol. 2010;20(7):607-11
pubmed: 21314003
Ann Allergy Asthma Immunol. 2012 Aug;109(2):137-40
pubmed: 22840256
Acta Derm Venereol. 1997 Jul;77(4):285-8
pubmed: 9228220
JAMA Netw Open. 2021 Dec 1;4(12):e2136662
pubmed: 34851398
Curr Allergy Asthma Rep. 2017 Aug;17(8):56
pubmed: 28752367
Open Forum Infect Dis. 2022 Mar 02;9(4):ofac106
pubmed: 35355888
J Cataract Refract Surg. 2022 Nov 1;48(11):1347-1348
pubmed: 36026700